60 Degrees Pharmaceuticals, Inc. Warrant
SXTPW
$0.03-22.86%
End of day · as of Sep 24, 2026, 8:02 AM ET
Mkt cap
N/A
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$1.01M
EPS (H1 2026)
$-2.00
Gross Margin (FY2025)
22.26%
Profit Margin (FY2025)
-732.51%
Beta
N/A
Div yield
N/A
Sector
Healthcare
60 Degrees Pharmaceuticals, Inc. Warrant (SXTPW) is a biotechnology company listed on NASDAQ.
Latest reported SXTPW revenue for 2025-12-31 was $1.0M. Net income was -$7.4M. Revenue was up 65.5% from 2024-12-31 to 2025-12-31.
Use this SXTPW research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full SXTPW income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
60 Degrees Pharmaceuticals, Inc. Warrant (SXTPW) is a biotechnology company in the Healthcare sector.
Latest cached 60 Degrees Pharmaceuticals, Inc. Warrant (SXTPW) revenue for Dec 31, 2025 was $1.0M. Net income was -$7.4M. Statements: https://lician.com/financials/sxtpw
60 Degrees Pharmaceuticals, Inc. Warrant (SXTPW) cached previous close $0.04; day range $0.03 – $0.03; volume 8,544. Session quote: https://lician.com/quote/sxtpw
The latest cached SXTPW filing is 8-K · Oct 6, 2026. Filings: https://lician.com/sec/sxtpw